Cargando…
S206: ONCO-FETAL REPROGRAMMING DRIVES HIGH-RISK JUVENILE MYELOMONOCYTIC LEUKEMIA, WHICH CAN BE TARGETED BY ANTI-CD52 TREATMENT
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428423/ http://dx.doi.org/10.1097/01.HS9.0000967736.39273.98 |
| _version_ | 1785090465604829184 |
|---|---|
| author | Hartmann, Mark Schönung, Maximilian Rajak, Jovana Hey, Joschka Maurer, Valentin Hai, Ling Staeble, Sina Langstein, Jens Bauer, Katharina Hakobyan, Mariam Jardine, Laura Bohler, Sheila Vonficht, Dominik Maag, Abdul-Habib Lebrecht, Dirk Bernt, Kathrin Rölz, Roland Boch, Tobias Khabirova, Eleonora Lutsik, Pavlo Haas, Simon Haniffa, Muzlifah Behjati, Sam Mallm, Jan-Philipp Buske, Christian Milsom, Michael Fröhling, Stefan Bonder, Marc-Jan Plass, Christoph Niemeyer, Charlotte Flotho, Christian Erlacher, Miriam Schlesner, Matthias Lipka, Daniel B. |
| author_facet | Hartmann, Mark Schönung, Maximilian Rajak, Jovana Hey, Joschka Maurer, Valentin Hai, Ling Staeble, Sina Langstein, Jens Bauer, Katharina Hakobyan, Mariam Jardine, Laura Bohler, Sheila Vonficht, Dominik Maag, Abdul-Habib Lebrecht, Dirk Bernt, Kathrin Rölz, Roland Boch, Tobias Khabirova, Eleonora Lutsik, Pavlo Haas, Simon Haniffa, Muzlifah Behjati, Sam Mallm, Jan-Philipp Buske, Christian Milsom, Michael Fröhling, Stefan Bonder, Marc-Jan Plass, Christoph Niemeyer, Charlotte Flotho, Christian Erlacher, Miriam Schlesner, Matthias Lipka, Daniel B. |
| author_sort | Hartmann, Mark |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428423 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104284232023-08-17 S206: ONCO-FETAL REPROGRAMMING DRIVES HIGH-RISK JUVENILE MYELOMONOCYTIC LEUKEMIA, WHICH CAN BE TARGETED BY ANTI-CD52 TREATMENT Hartmann, Mark Schönung, Maximilian Rajak, Jovana Hey, Joschka Maurer, Valentin Hai, Ling Staeble, Sina Langstein, Jens Bauer, Katharina Hakobyan, Mariam Jardine, Laura Bohler, Sheila Vonficht, Dominik Maag, Abdul-Habib Lebrecht, Dirk Bernt, Kathrin Rölz, Roland Boch, Tobias Khabirova, Eleonora Lutsik, Pavlo Haas, Simon Haniffa, Muzlifah Behjati, Sam Mallm, Jan-Philipp Buske, Christian Milsom, Michael Fröhling, Stefan Bonder, Marc-Jan Plass, Christoph Niemeyer, Charlotte Flotho, Christian Erlacher, Miriam Schlesner, Matthias Lipka, Daniel B. Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428423/ http://dx.doi.org/10.1097/01.HS9.0000967736.39273.98 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Oral Sessions Hartmann, Mark Schönung, Maximilian Rajak, Jovana Hey, Joschka Maurer, Valentin Hai, Ling Staeble, Sina Langstein, Jens Bauer, Katharina Hakobyan, Mariam Jardine, Laura Bohler, Sheila Vonficht, Dominik Maag, Abdul-Habib Lebrecht, Dirk Bernt, Kathrin Rölz, Roland Boch, Tobias Khabirova, Eleonora Lutsik, Pavlo Haas, Simon Haniffa, Muzlifah Behjati, Sam Mallm, Jan-Philipp Buske, Christian Milsom, Michael Fröhling, Stefan Bonder, Marc-Jan Plass, Christoph Niemeyer, Charlotte Flotho, Christian Erlacher, Miriam Schlesner, Matthias Lipka, Daniel B. S206: ONCO-FETAL REPROGRAMMING DRIVES HIGH-RISK JUVENILE MYELOMONOCYTIC LEUKEMIA, WHICH CAN BE TARGETED BY ANTI-CD52 TREATMENT |
| title | S206: ONCO-FETAL REPROGRAMMING DRIVES HIGH-RISK JUVENILE MYELOMONOCYTIC LEUKEMIA, WHICH CAN BE TARGETED BY ANTI-CD52 TREATMENT |
| title_full | S206: ONCO-FETAL REPROGRAMMING DRIVES HIGH-RISK JUVENILE MYELOMONOCYTIC LEUKEMIA, WHICH CAN BE TARGETED BY ANTI-CD52 TREATMENT |
| title_fullStr | S206: ONCO-FETAL REPROGRAMMING DRIVES HIGH-RISK JUVENILE MYELOMONOCYTIC LEUKEMIA, WHICH CAN BE TARGETED BY ANTI-CD52 TREATMENT |
| title_full_unstemmed | S206: ONCO-FETAL REPROGRAMMING DRIVES HIGH-RISK JUVENILE MYELOMONOCYTIC LEUKEMIA, WHICH CAN BE TARGETED BY ANTI-CD52 TREATMENT |
| title_short | S206: ONCO-FETAL REPROGRAMMING DRIVES HIGH-RISK JUVENILE MYELOMONOCYTIC LEUKEMIA, WHICH CAN BE TARGETED BY ANTI-CD52 TREATMENT |
| title_sort | s206: onco-fetal reprogramming drives high-risk juvenile myelomonocytic leukemia, which can be targeted by anti-cd52 treatment |
| topic | Oral Sessions |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428423/ http://dx.doi.org/10.1097/01.HS9.0000967736.39273.98 |
| work_keys_str_mv | AT hartmannmark s206oncofetalreprogrammingdriveshighriskjuvenilemyelomonocyticleukemiawhichcanbetargetedbyanticd52treatment AT schonungmaximilian s206oncofetalreprogrammingdriveshighriskjuvenilemyelomonocyticleukemiawhichcanbetargetedbyanticd52treatment AT rajakjovana s206oncofetalreprogrammingdriveshighriskjuvenilemyelomonocyticleukemiawhichcanbetargetedbyanticd52treatment AT heyjoschka s206oncofetalreprogrammingdriveshighriskjuvenilemyelomonocyticleukemiawhichcanbetargetedbyanticd52treatment AT maurervalentin s206oncofetalreprogrammingdriveshighriskjuvenilemyelomonocyticleukemiawhichcanbetargetedbyanticd52treatment AT hailing s206oncofetalreprogrammingdriveshighriskjuvenilemyelomonocyticleukemiawhichcanbetargetedbyanticd52treatment AT staeblesina s206oncofetalreprogrammingdriveshighriskjuvenilemyelomonocyticleukemiawhichcanbetargetedbyanticd52treatment AT langsteinjens s206oncofetalreprogrammingdriveshighriskjuvenilemyelomonocyticleukemiawhichcanbetargetedbyanticd52treatment AT bauerkatharina s206oncofetalreprogrammingdriveshighriskjuvenilemyelomonocyticleukemiawhichcanbetargetedbyanticd52treatment AT hakobyanmariam s206oncofetalreprogrammingdriveshighriskjuvenilemyelomonocyticleukemiawhichcanbetargetedbyanticd52treatment AT jardinelaura s206oncofetalreprogrammingdriveshighriskjuvenilemyelomonocyticleukemiawhichcanbetargetedbyanticd52treatment AT bohlersheila s206oncofetalreprogrammingdriveshighriskjuvenilemyelomonocyticleukemiawhichcanbetargetedbyanticd52treatment AT vonfichtdominik s206oncofetalreprogrammingdriveshighriskjuvenilemyelomonocyticleukemiawhichcanbetargetedbyanticd52treatment AT maagabdulhabib s206oncofetalreprogrammingdriveshighriskjuvenilemyelomonocyticleukemiawhichcanbetargetedbyanticd52treatment AT lebrechtdirk s206oncofetalreprogrammingdriveshighriskjuvenilemyelomonocyticleukemiawhichcanbetargetedbyanticd52treatment AT berntkathrin s206oncofetalreprogrammingdriveshighriskjuvenilemyelomonocyticleukemiawhichcanbetargetedbyanticd52treatment AT rolzroland s206oncofetalreprogrammingdriveshighriskjuvenilemyelomonocyticleukemiawhichcanbetargetedbyanticd52treatment AT bochtobias s206oncofetalreprogrammingdriveshighriskjuvenilemyelomonocyticleukemiawhichcanbetargetedbyanticd52treatment AT khabirovaeleonora s206oncofetalreprogrammingdriveshighriskjuvenilemyelomonocyticleukemiawhichcanbetargetedbyanticd52treatment AT lutsikpavlo s206oncofetalreprogrammingdriveshighriskjuvenilemyelomonocyticleukemiawhichcanbetargetedbyanticd52treatment AT haassimon s206oncofetalreprogrammingdriveshighriskjuvenilemyelomonocyticleukemiawhichcanbetargetedbyanticd52treatment AT haniffamuzlifah s206oncofetalreprogrammingdriveshighriskjuvenilemyelomonocyticleukemiawhichcanbetargetedbyanticd52treatment AT behjatisam s206oncofetalreprogrammingdriveshighriskjuvenilemyelomonocyticleukemiawhichcanbetargetedbyanticd52treatment AT mallmjanphilipp s206oncofetalreprogrammingdriveshighriskjuvenilemyelomonocyticleukemiawhichcanbetargetedbyanticd52treatment AT buskechristian s206oncofetalreprogrammingdriveshighriskjuvenilemyelomonocyticleukemiawhichcanbetargetedbyanticd52treatment AT milsommichael s206oncofetalreprogrammingdriveshighriskjuvenilemyelomonocyticleukemiawhichcanbetargetedbyanticd52treatment AT frohlingstefan s206oncofetalreprogrammingdriveshighriskjuvenilemyelomonocyticleukemiawhichcanbetargetedbyanticd52treatment AT bondermarcjan s206oncofetalreprogrammingdriveshighriskjuvenilemyelomonocyticleukemiawhichcanbetargetedbyanticd52treatment AT plasschristoph s206oncofetalreprogrammingdriveshighriskjuvenilemyelomonocyticleukemiawhichcanbetargetedbyanticd52treatment AT niemeyercharlotte s206oncofetalreprogrammingdriveshighriskjuvenilemyelomonocyticleukemiawhichcanbetargetedbyanticd52treatment AT flothochristian s206oncofetalreprogrammingdriveshighriskjuvenilemyelomonocyticleukemiawhichcanbetargetedbyanticd52treatment AT erlachermiriam s206oncofetalreprogrammingdriveshighriskjuvenilemyelomonocyticleukemiawhichcanbetargetedbyanticd52treatment AT schlesnermatthias s206oncofetalreprogrammingdriveshighriskjuvenilemyelomonocyticleukemiawhichcanbetargetedbyanticd52treatment AT lipkadanielb s206oncofetalreprogrammingdriveshighriskjuvenilemyelomonocyticleukemiawhichcanbetargetedbyanticd52treatment |